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Abstract
Background: Protease-activated receptors (PARs) are G-protein-coupled receptors with an active role in mediating
inflammation, pain and other functions. The oral pathogen Porphyromonas gingivalis (P. gingivalis) secretes proteases
that activate PARs. The aim of this study was to elucidate the role of PARs in the pathogenesis of chronic
periodontitis by expression analysis of PARs in human gingival epithelial cells (GECs) before and after P. gingivalis
supernatants treatment.
Methods: GECs were isolated from healthy human gingival tissue samples. The expression of PARs in GECs was
determined by reverse transcription-polymerase chain reaction (RT-PCR) and flow cytometry. The effect of P.
gingivalis proteases was investigated by quantitative real-time reverse transcription polymerase chain reaction
(QRT-PCR) and flow cytometry.
Results: PAR-1, PAR-2, and PAR-3 were expressed in GECs. PAR-4 was not found by both RT-PCR and flow
cytometry. Analysis of gene expression using QRT-PCR showed an up-regulation of PAR-2 mRNA in comparison to
the untreated control cells (P < 0.05). In contrast, the mRNA expressions of PAR-1 and PAR-3 were significantly
down-regulated (P > 0.05) in response to P. gingivalis supernatant compared to that in unstimulated control cells.
This effect was abrogated by the protease inhibitor TLCK (P < 0.05). The results of flow cytometry indicated PARs
protein levels consistent with mRNA levels in the results of QRT-PCR.
Conclusions: Our study shows that PAR-1, PAR-2 and PAR-3 are expressed in GECs. P. gingivalis proteases play a
role in the regulation of innate immune responses in GECs. GECs use PARs to recognize P. gingivalis and mediate
cell responses involved in innate immunity.
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Background
Protease-activated receptors (PARs) are a subfamily of G
protein-coupled receptors (GPCRs) with four members,
PAR-1, PAR-2, PAR-3 and PAR-4, which play critical
roles in hemostasis, thrombosis, embryonic develop-
ment, wound healing, inflammation and cancer progres-
sion [1]. The activation of PARs occurs by a unique
mechanism that involved specific proteolytic cleavage of
the N-terminal extracellular sequence by a protease.
This cleavage unmasks a new N-terminal sequence,
which acts as a tethered ligand that binds to the receptor
to initiate multiple signaling cascades [2–4]. Although
they share the same mechanism of action, it has been
shown that different PARs are characterized by different
distributions and biological actions and can be activated
by different proteases [5]. Thrombin is a major activator
of PAR-1, PAR-2 and PAR-3. Other important activators
of PAR-1 include activated protein C (APC) and matrix
metalloproteinase-1 (MMP-1); whereas trypsin and hu-
man mast cell tryptase activate PAR-2 and trypsin and
cathepsin G activate PAR-4. In terms of eliciting down-
stream signaling responses, PAR-1, PAR-2 and PAR-4
can signal autonomously, while PAR-3 is mainly consid-
ered to be a co-receptor for PAR-1 and PAR-4 [6–9]. As
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PARs are expressed in a wide variety of cell types, it has
recently been suggested that they play important roles in
physiological processes, such as growth, development,
inflammation, tissue repair and pain.
The gingival epithelium is becoming known as a regu-
lator of the oral innate immune response to a variety of
insults, such as bacteria and chemicals. Human gingival
epithelial cells (GECs), which are key factors of innate
immunity, not only play an important role in maintain-
ing the physical barrier between the host and the envir-
onment but also actively participate in tissue innate
immunity [10, 11] by specifically expressing certain re-
ceptors that are involved in the host immune response.
It is widely accepted that cells utilize pattern recognition
receptors to identify bacteria in their environment [12,
13]; however, in addition, some pathogens, such as Por-
phyromonas gingivalis (P. gingivalis), secrete proteases
that are recognized by cells via the family of PARs [14].
PARs are known to be expressed in the epithelium of
gingiva and have been implicated in the pathogenesis of
periodontitis [15–18].
Periodontitis is a chronic infectious disease that starts
as inflammation of the periodontal tissues and finally
causes resorption of alveolar bone and subsequent loss
of teeth. P. gingivalis is a major causative agent of
chronic periodontitis. This bacterium produces and re-
leases a large amount of proteolytic enzymes. Trypsin-
like proteinases, called gingipains, produced by P. gingi-
valis have been shown to act as important pathogenic
agents [19, 20]. Recently, it has been shown that gingi-
pains are recognized by cells via the family of PARs,
which are involved in inflammatory processes in several
tissues. However, the precise roles of PARs in gingival
tissues and the importance of specific PARs in the
pathogenesis of periodontitis remain to be elucidated. In
the present study, reverse transcription-polymerase
chain reaction (RT-PCR) was used to investigate the
mRNA levels of PARs and flow cytometry was used to
investigate the protein levels of PARs in GECs. Further-
more, quantitative real-time RT-PCR (QRT-PCR) was
used to investigate the mRNA levels of PARs in response
to cell-free supernatant from P. gingivalis in order to
corroborate the roles of the secreted proteases.
Methods
Gingival epithelial cell culture
Primary human GECs were isolated from healthy human
gingival tissue samples from patients undergoing third
molar extraction at the Dental Department, Sir Run Run
Shaw Hospital, School of Medicine, Zhejiang University,
China. Written informed consent was obtained from all
individuals participating in this study. The study were
evaluated and approved by the Ethics Committee of the
Affiliated Sir Run Run Show Hospital of Zhejiang
University School of Medicine (20131120). Fresh gum
tissue was placed into D-Hanks containing 300 U/ml
penicillin G and 300 μg/ml streptomycin and incubated
at 4 °C. Within 1 h, tissue was prepared to obtain epithe-
lial cells. Briefly, the tissue was cut into small pieces
(1 mm × 1 mm), treated with a solution of 25 % dispase
II (Sigma–Aldrich, St Louis, MO, USA) and incubated
for 18 h at 4 °C. After incubation, the epidermal layer of
human keratinocytes was lifted from the dermis and
placed into a 15 ml sterile centrifuge tube containing
2 ml trypsin–EDTA. The tissue was incubated at 37 °C
for approximately 10 min. Subsequently, isolated GECs
were seeded into T-75 flasks (BD Biosciences) at a cell
density of approximately 3 × 106 cells per flask in 10–15 ml
serum-free keratinocyte medium (keratinocyte-SFM) to
which supplements were added according to the manu-
facturer’s instructions (Gibco BRL, Life Technologies,
Rockville, MD, USA). Fluids in the flasks were ex-
changed for fresh complete medium and gassed with
5 % CO2 every 2–3 days. Cells were passaged when
75–80 % confluence was reached.
Reverse transcription-PCR (RT-PCR) analysis for the deter-
mination of PARs expression
To examine the expression of PARs mRNA, total RNA
was isolated from GECs (grown to 70 % confluence)
using TRIzol® reagent (Gibco BRL, Life Technologies,
Rockville, MD, USA) according to the manufacturer’s
suggested protocol. The synthesis of the first strand
cDNA and RT-PCR were performed using a Prome-
Script® RT-PCR Kit (Takara Biotechnology Co., Ltd, Da-
lian, China). The primers for PAR-1, PAR-2, PAR-3,
PAR-4 and β-actin were synthesized by Sangon Biotech
Co., Ltd (Shanghai, China; Table 1). For amplification of
PAR-1, PAR-2 and β-actin products, PCR was performed
for 30 cycles. The first cycle included a denaturation step
of 5 min at 94 °C. Cycles 2–30 had a denaturation step
of 30 s at 94 °C, 30 s of annealing at 60 °C and 45 s of
elongation at 72 °C. The last cycle included an elong-
ation step of 10 min at 72 °C. For PAR-3 and PAR-4
amplification, PCR was performed for 30 cycles. The
first cycle included a denaturation step of 5 min at
94 °C. Cycles 2–30 had a denaturation step of 30 s at
94 °C, 30 s of annealing at 65 °C and 45 s of elongation at
72 °C. The last cycle included an elongation step of
10 min at 72 °C. DNA products and molecular weight
marker DL1,000™ DNA Marker (Takara Biotechnology
Co., Ltd, Dalian, China) were separated in 1.5 % agarose
gel, after which the gels were stained with GelRed™
and visualized under UV light.
Bacteria culture and supernatants collection
P. gingivalis ATCC 33277 was purchased from the
American Type Culture Collection (Manassas, VA, USA)
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and anaerobically cultured (80 % N2, 10 % H2 and 10 %
CO2) in a brain–heart infusion (BHI; Oxoid) agar plate
containing 5 % defibrinated sheep blood enriched with
5 g/l yeast extract, 5 mg/l hemin and 10 mg/l menadione
(Sigma–Aldrich, Dorset, UK) at 37 °C for up to 5 weeks.
Liquid cultures were prepared by inoculation of bacterial
colonies (3–4 days old) from blood agar plates into
10 ml BHI broth supplemented with 5 g/l yeast extract,
5 mg/l hemin and 10 mg/l menadione and incubated for
24 h. Ten percent inoculum was transferred to 90 ml of
the same medium and incubated for 6 days. After this
culture period, bacteria were harvested by centrifugation
at 10,000 g for 15 min at 4 °C and supernatants were
collected, filter-sterilized over a 0.2 mm filter and
stored at −80 °C until use. Before treatment, aliquots
of the supernatant were used for pre-incubation
(10 min) with 1 mmol/l of the serine and cysteine
protease inhibitor tosyl-L-lysine chloromethylketone
(TLCK; Sigma–Aldrich, St Louis, MO, USA), which
inhibits gingipains [15, 21].
Characterization of bacterial culture supernatants and
treatment
P. gingivalis supernatants were diluted in cell culture
medium and their concentration expressed as the
total bacterial protein (mg/ml) present in the cell
cultures. The protein concentration was determined
with a BCA Protein Assay Kit (Pierce, Rockford, IL,
USA). Absorbance was measured at 562 nm on a
SpectraMax® Plus plate reader. Protease activity was
measured with a Protease Assay™ Kit (G-Biosciences,
St Louis, MO, USA) [22]. The absorbance of the
dye-labeled peptide was measured at 570 nm for de-
termination of the protease activity. Chemically stabi-
lized trypsin (MSG-Trypsin™) was supplied with the
kit as a general protease standard. GECs were grown
to 80 % confluence and stimulated with either 50 μg/ml
culture supernatant protein from P. gingivalis superna-
tants or TLCK-preincubated supernatants, for 6 h [22].
Unstimulated GEC medium served as a control for the
stimulation experiments. Each stimulation experiment
was performed in triplicate and cells from two to five
different donors were tested.
Quantitative real-time RT-PCR (QRT-PCR)
After stimulation, total RNA was extracted using an
RNeasy Kit (Qiagen, Valencia, CA, USA) and reverse-
transcribed using a SuperScript® RT-PCR Kit (Takara,
Tokyo, Japan). Quantitative real-time RT-PCR was per-
formed using the Applied Biosystems 7500 PCR machine
and SYBR Premix Kit (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer’s instructions. PCRs were
carried out in 96-well plates in a total volume of 20 μl,
including 1 μl cDNA and 0.8 μl primers (10 μM; Table 2).
Sample expression was normalized against that of the
housekeeping gene β-actin, which was included in each
QPCR run. PCR controls were performed using water
instead of cDNA. All reactions were carried out in dupli-
cate. At each time point, the expressions of the selected
mRNAs in cells incubated with P. gingivalis supernatants
or TLCK-preincubated supernatants were calculated rela-
tive to the housekeeping gene β-actin (ΔCt) for each sam-
ple and then expressed relative to untreated cells at the
same time point using the 2-ΔΔCt method [23].
Flow cytometry
Cells were washed in phosphate-buffered saline (PBS),
incubated for 30 min at 4 °C with PBS containing 20 %
heat-inactivated normal human serum, washed again
and then incubated for 30 min at 4 °C with 15 nM of
specific monoclonal antibodies (mAb) to human PAR-1–4
(PE-conjugated; Santa Cruz Biotechnology, Inc., Santa
Cruz, CA, USA). Flow cytometry analyses were performed
on a FACScan (BD Biosciences, San Jose, CA, USA).
Control cells incubated with PE-conjugated nonspe-
cific antibodies obtained from the same manufacturers
were used to set the threshold for the fluorescence
parameter, such that the fraction of cells with positive
Table 1 Oligonucleotide sequences used for RT-PCR
Primers Oligonucleotide sequence Length (bp)
Sense (5’ to 3’) Antisense (5’ to 3’)
PAR-1 CCCGCAGGCCAGAATCAAA AAAGGGGAGCACAGACACAAACAG 395
PAR-2 CTACTCAGATGACCCCAGAAACT CCCAAAGTGCTAGGATTACAGG 399
PAR-3 GGCTGGACAGGAGCCACGAT AGCGGTTGATGCTGATGCAGG 403
PAR-4 GGATCGCCTACCACCTGCGTG CCCGTAGCACAGCAGCATGG 401
β-actin AGGGGCCGGACTCGTCATACT GGCGGCAACACCATGTACCCT 202
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fluorescence was <2.5 % of the total cells. The per-
centage of PAR-1–4 positive cells was determined
from the fraction of cells in the sample incubated
with specific antibodies that exceeded the threshold
for the fluorescence signal intensity obtained with the
control sample.
Statistical analyses
All data are shown as the mean ± the standard deviations
(SD). QRT-PCR data are expressed as Ct (cycle threshold),
ΔCt (Ct PAR mRNA – Ct β-actin mRNA) and relative
quantification (RQ; expressed as fold change). The fold
changes of PARs mRNA expression were calculated using
the 2-ΔΔCt method [23]. Student’s t-test was used for
comparison between two groups. SPSS version 19.0
(SPSS Inc., Chicago, IL, USA) was used for statistical ana-
lysis and P ≤ 0.05 was considered statistically significant.
Results
RT-PCR analysis of PARs in GECs
RT-PCR analysis of RNA extracted from GECs revealed
the presence of PAR-1, PAR-2 and PAR-3 mRNA (Fig. 1).
No PCR product was found for PAR-4 (Fig. 1). The re-
sult shows that PAR-1, PAR-2 and PAR-3 are expressed
in GECs, but PAR-4 is not.
P. gingivalis supernatant alters PARs gene expression
The proteolytic activity of the supernatant from P. gingi-
valis was demonstrated after 4, 8 and 16 h. Preincuba-
tion of the supernatant with the protease inhibitor
TLCK showed significantly reduced proteolytic activity
compared to that in native supernatant after 4 and 8 h
(P < 0.05; Fig. 2). To evaluate the effect of the P. gingiva-
lis supernatant on the expression of PAR-1, PAR-2 and
PAR-3 mRNAs, GECs were grown to 80 % confluence
and stimulated with the supernatant for 6 h. Analysis of
gene expression using QRT-PCR showed upregulation of
PAR-2 mRNA in comparison to untreated control cells
(P < 0.05; Fig. 3b). In contrast, the mRNA expressions
of PAR-1 and PAR-3 were significantly downregulated
(P < 0.05) in response to P. gingivalis supernatant com-
pared to that of unstimulated control cells (Fig. 3a, c). Pre-
incubation of the P. gingivalis supernatant with the
protease inhibitor TLCK abolished the effect and restored
the PARs mRNA expression levels to that of untreated
cells. Controls establish using blank bacterial medium and
TLCK showed no effect on the mRNA expression of PAR-
1, PAR-2 and PAR-3 (Fig. 3). The results were consistent
with previous studies [22].
PARs protein expression assessed by flow cytometry
Flow cytometry showed protein expression of PAR-1,
PAR-2 and PAR-3 by GECs, but no PAR-4 expression
(Fig. 4). After P. gingivalis supernatant treatment for 6 h,
the protein expression of PAR-2 was upregulated com-
pared to untreated control cells (P < 0.05; Fig. 5). Con-
versely, the protein levels of PAR-1 and PAR-3 were
significantly downregulated after treatment (P < 0.05).
The results of flow cytometry indicated PARs protein
levels consistent with mRNA levels in the results of
QRT-PCR.
Discussion
Periodontitis is an infection of periodontal tissues which
are the supportive structure for the teeth. In the com-
plex structure of periodontal tissues, gingival epithelium
is directly exposed to periodontal bacteria and their
products, by receiving and transmitting signals, plays an
important role in the overall dialogue that occurs be-
tween pathogens and the host. PARs are expressed and
function on GECs as a part of the immuno-surveillance
system. These receptors are clearly important for GECs
responses to the environment that may include patho-
genic or physiological products.
Four PAR family members (PAR-1, −2, −3, and −4)
have been identified so far. In this study we showed that
PAR-1, PAR-2 and PAR-3 are expressed in GECs, but
PAR-4 is not expressed in GECs. Many researchers have
already reported the expression of PARs in a wide var-
iety of cell types, while there was controversy about the
expression of PARs [2, 3, 13, 17]. There are also some
studies about the expression of PARs in GECs, but most
studies were concerned on the expression and the roles
of PAR-2. Overexpression of PAR-2 has been positively
associated with inflammatory clinical parameters and
Fig. 1 RT-PCR analysis of PARs mRNA in GECs. RT-PCR was performed
using the primers specific to each type of PAR, as described in Table 1.
The PCR products were subjected to electrophoresis through a 1.5 %
agarose gel. Lines 1–6 represent β-actin, PAR-4, PAR-3, PAR-2, PAR-1
and Marker separately. RT-PCR analysis revealed the presence of PAR-1,
PAR-2 and PAR-3 mRNA in GECs. No PCR product was found for PAR-4
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with the levels of interleukin-6 (IL-6), IL-8, tumor ne-
crosis factor alpha, matrix metalloprotease-2 (MMP-2),
MMP-8, hepatocyte growth factor and vascular endothe-
lial growth factor [5, 24, 25]. Only one research found
PAR-1, PAR-2 and PAR-3 expression in KB cells by RT-
PCR and PAR-1, PAR-2 and PAR-3 expression in GECs by
immunohistochemical studies [17]. In our study, RT-PCR
and flow cytometry were used to analyse the expression of
PARs. The results were corroborated the PAR-1, PAR-2
and PAR-3 expression in GECs.
In gingival epithelium, arginine-specific cysteine prote-
ases (Arg-gingipain, Rgp) from P. gingivalis, a major
pathogen associated with chronic periodontitis, activate
PARs and induce expression of inflammatory cytokines
[22, 26, 27]. The PAR family is structurally unrelated to
the pattern recognition receptor family (PRR) but, like
PRRs, they signal potential danger in the environment
by activating innate immune markers and inflammatory
responses [28]. However, little is known about their
function when they are activated by their agonist enzymes,
thrombin and trypsin or trypsin-like enzymes, in gingival
epithelium. PARs are expressed by a wide variety of cell
types and are suggested to play important roles in physio-
logical processes, such as growth, development, inflamma-
tion, tissue repair and pain [29]. Our study demonstrated
that the expression of PAR-2 was upregulated with P. gin-
givalis supernatant treatment compared to untreated con-
trol cells. Conversely, PAR-1 and PAR-3 expression was
Fig. 2 The protease activities of P. gingivalis supernatant or TLCK-preincubated supernatant. Protease activity was measured with a Protease Assay™ Kit
and was monitored for 4, 8 and 16 h. The absorbance of the dye-labeled peptide was measured at 570 nm for determination of the protease activity.
Native supernatant showed significantly higher proteolytic activity than TLCK-preincubated supernatant after 4 and 8 h. Triplicate measurements were
performed. Data are shown as the mean with the standard deviation (mean ± SD). *, P < 0.05, compared with native supernatant values
Fig. 3 PAR-1 (a), PAR-2 (b) and PAR-3 (c) gene expression in response to P. gingivalis supernatant. PARs gene expression was evaluated by quantitative
real-time RT-PCR (QRT-PCR) in response to cell-free supernatant from P. gingivalis and TLCK-preincubated supernatant in GECs. After P. gingivalis
supernatant treatment, the expression of PAR-2 was upregulated compared to untreated control cells. Conversely, PAR-1 and PAR-3 expression was
significantly downregulated. Data are shown as the mean with the standard deviation (mean ± SD). *, P < 0.05, compared with control values. Control:
without supernatant stimulation. P. gingivalis S: P. gingivalis supernatant
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significantly downregulated, after P. gingivalis supernatant
treatment. In fact, PAR-2 activation has been associated
with several chronic inflammatory conditions [3, 30–32].
Furthermore, in vitro and in vivo studies have clearly
suggested that PAR-2 also plays a role in periodontal
inflammation [15, 16, 33, 34]. PAR-1 activation, via throm-
bin or man-made activating peptides, has been implicated
as a potential regulator of both pain and inflammation
[35–37]. A recent study also showed that PAR-1 was
expressed in gingival tissues [18] and PAR-1 activation by
thrombin may play a role in the repair and homeostasis of
periodontal tissues [38]. The role of PAR-3 is of interest
because the function of this apparently non-signaling re-
ceptor remains obscure [9, 39, 40]. The ability of PAR-3 to
generate an intracellular signal also remains in doubt be-
cause it lacks the cytoplasmic tail domain shown in other
PARs, which is required to couple with G-proteins [9]. A
recent study has demonstrated that PAR-3 is a critical
determinant of PAR-1 function and PAR-3 may mitigate
the effects of PAR-1 in activating endothelial responses,
such as vascular inflammation [41]. PAR-3 regulates PAR1
signaling by receptor dimerization. There has been
controversy over the role of PARs. In some tissues
they play a proinflammatory role [42], while in other
tissues they seem to have an anti-inflammatory or
protective effect [43]. This protective function may be fa-
cilitated by the upregulation of PAR-2 and the downregu-
lation of PAR-1 and PAR-3 gene expression in response to
P. gingivalis proteases. However, further studies are re-
quired to fully elucidate the roles of PAR-1, PAR-2, and
PAR-3 in the pathogenesis of periodontitis.
Conclusions
The study described here confirms the roles of PAR-1,
PAR-2 and PAR-3 in gingival epithelial responses that may
be related to periodontal inflammation. Consequently, the
Fig. 4 Protein level of PARs in GECs by flow cytometry. a, b, c and d show representative results from the flow cytometric analyses of PAR-1,
PAR-2, PAR-3 and PAR-4, respectively. The result showed GECs expressed PAR-1, PAR-2 and PAR-3, but not PAR-4. Black line: isotype control. Green
line: anti-PARs
Fig. 5 PAR-1 (a), PAR-2 (b) and PAR-3 (c) protein expression in response to P. gingivalis supernatant. PARs expression was evaluated by flow cytometry
in response to cell-free supernatant from P. gingivalis and TLCK-preincubated supernatant in GECs. Flow cytometry analyses were performed on a
FACScan. After P. gingivalis supernatant treatment for 6 h, the expression of PAR-2 was upregulated compared to untreated control cells. Conversely,
PAR-1 and PAR-3 expression was significantly downregulated after treatment. Data are shown as the mean with the standard deviation
(mean ± SD). *, P < 0.05, compared with control values. Control: without supernatant stimulation. P. gingivalis S: P. gingivalis supernatant
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detailed mechanisms underlying the effects mediated
by the major PARs in periodontitis, including their
correlation with cytokines, require further research.
This information will provide a better understanding
of the development of periodontal diseases and in-
form the strategy for the identification of therapeutic
approaches for these conditions.
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